BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31414912)

  • 1. Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations.
    Pagnoux C; Mendel A
    Expert Rev Clin Immunol; 2019 Sep; 15(9):939-949. PubMed ID: 31414912
    [No Abstract]   [Full Text] [Related]  

  • 2. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes.
    Allen NB; Bressler PB
    Med Clin North Am; 1997 Jan; 81(1):243-59. PubMed ID: 9012763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
    Terrier B; Darbon R; Durel CA; Hachulla E; Karras A; Maillard H; Papo T; Puechal X; Pugnet G; Quemeneur T; Samson M; Taille C; Guillevin L;
    Orphanet J Rare Dis; 2020 Dec; 15(Suppl 2):351. PubMed ID: 33372616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microscopic polyangiitis].
    Pagnoux C; Guilpain P; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):895-901. PubMed ID: 17350793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].
    Lamprecht P; Ahmadi-Simab K; Gross WL; Hellmich B
    Med Klin (Munich); 2006 Mar; 101(3):212-25. PubMed ID: 16648979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic vasculitis and the gut.
    Hatemi I; Hatemi G; Çelik AF
    Curr Opin Rheumatol; 2017 Jan; 29(1):33-38. PubMed ID: 27684357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uptodate in the management and treatment of ANCA-associated vasculitis].
    Belaconi IN; Toma CL; Bogdan MA
    Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis.
    Jung M; Barra L
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):129-134. PubMed ID: 29799394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ANCA-associated vasculitis].
    Holle JU
    Internist (Berl); 2015 Jan; 56(1):41-50; quiz 51-2. PubMed ID: 25502657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyarteritis nodosa.
    Forbess L; Bannykh S
    Rheum Dis Clin North Am; 2015; 41(1):33-46, vii. PubMed ID: 25399938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteric vasculitis, an unusual presentation of polyarteritis nodosa: a case report.
    Jois R; Gupta A; Krishnamurthy S
    Int J Rheum Dis; 2015 Jun; 18(5):577-9. PubMed ID: 25925589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy of vasculitis: current aspects and perspectives].
    Giacomelli R; Pizzuto F; Cucinelli F; Tonietti G
    Recenti Prog Med; 1996 Mar; 87(3):124-34. PubMed ID: 8650433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.
    Frankel SK; Sullivan EJ; Brown KK
    Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons.
    Reggiani F; Stella M; Calatroni M; Sinico RA
    Expert Rev Clin Immunol; 2024 Jul; 20(7):765-780. PubMed ID: 38445642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cholecystitis at initial presentation of polyarteritis nodosa.
    Fernandes SR; Samara AM; Magalhães EP; Sachetto Z; Metze K
    Clin Rheumatol; 2005 Nov; 24(6):625-7. PubMed ID: 15789142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):541-4. PubMed ID: 18524111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.